Skip to main content
. Author manuscript; available in PMC: 2013 Jul 14.
Published in final edited form as: Int J Tuberc Lung Dis. 2013 Mar;17(3):373–380. doi: 10.5588/ijtld.12.0464

Table 1.

Treatment outcome among patients confirmed to have non-MDR-TB at initial diagnosis and throughout treatment in Moldova, 2007–2010

Case type
New, n (%) Previously treated
Total*, n (%)
Relapse, n (%) Return from default, n (%) After failure, n (%) Chronic, n (%) All previously treated, n (%)
Cured 1987 (52.4) 298 (45.5) 64 (22.9) 57 (41.9) 1 (6.3) 420 (38.6) 2409 (49.3)
Completed 795 (21.0) 93 (14.2) 19 (6.8) 9 (6.6) 2 (12.5) 123 (11.3) 919 (18.8)
Failed treatment 182 (4.8) 44 (6.7) 20 (7.1) 22 (16.2) 0 (0.0) 86 (7.9) 270 (5.5)
Defaulted 437 (11.5) 135 (20.6) 117 (41.8) 24 (17.6) 3 (18.8) 279 (25.7) 719 (14.7)
Died 249 (6.6) 62 (9.5) 45 (16.1) 17 (12.5) 7 (43.8) 131 (12.1) 382 (7.8)
Still on treatment as of 14 Sept 2011 141 (3.7) 23 (3.5) 15 (5.4) 7 (5.1) 3 (18.8) 48 (4.4) 191 (3.9)
Total 3791 655 280 136 16 1087 4890
Excluding those still on treatment as of 14 Sept 2011
Total 3650 632 265 129 13 1039 4699
Percentage defaulted 12.0 21.4 44.2 18.6 23.1 26.9 15.3
*

Includes an additional 12 cases that initiated treatment abroad